Lyra Therapeutics Inc.
(LYRA)
undefined
undefined%
At close: undefined
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Revenue | 1.56M | 1.36M | 285.00K | - | - | 1.24M |
| Cost of Revenue | - | 1.07M | 1.00M | 95.00K | 27.00K | - |
| Gross Profit | 1.56M | 296.00K | -716.00K | -95.00K | -27.00K | 1.24M |
| Operating Income | -67.12M | -56.31M | -43.62M | -22.21M | -16.52M | -7.26M |
| Interest Income | 4.50M | 1.04M | 102.00K | 82.00K | 213.00K | - |
| Pretax Income | -62.62M | -55.27M | -43.51M | -22.13M | -16.31M | -6.03M |
| Net Income | -62.68M | -55.28M | -42.41M | -22.05M | -16.09M | -6.03M |
| Selling & General & Admin | 19.06M | 17.56M | 14.21M | 9.69M | 4.49M | 3.53M |
| Research & Development | 48.03M | 38.80M | 29.69M | 12.52M | 12.03M | 4.97M |
| Other Expenses | 1.59M | 1.32M | - | - | - | 1.19M |
| Operating Expenses | 68.68M | 56.35M | 43.90M | 22.21M | 16.52M | 8.50M |
| Interest Expense | - | 524.00K | - | - | - | - |
| Selling & Marketing Expenses | - | - | - | - | - | - |
| Cost & Expenses | 68.68M | 56.35M | 43.90M | 22.21M | 16.52M | 8.50M |
| Income Tax | 59.00K | 13.00K | -1.10M | -82.00K | -213.00K | -1.23M |
| Shares Outstanding (Basic) | 49.80M | 30.24M | 12.99M | 8.59M | 12.92M | 6.27M |
| Shares Outstanding (Diluted) | 49.80M | 30.24M | 12.99M | 8.59M | 12.92M | 6.27M |
| EPS (Basic) | -1.26 | -1.83 | -3.27 | -2.57 | -1.25 | -0.96 |
| EPS (Diluted) | -1.26 | -1.83 | -3.27 | -2.57 | -1.25 | -0.96 |
| EBITDA | -65.25M | -53.92M | -42.61M | -22.11M | -16.49M | -7.18M |
| Depreciation & Amortization | 278.00K | 1.07M | 1.00M | 95.00K | 27.00K | 82.00K |